Their relevance within the domain of gut science continues to intrigue researchers due to their diverse properties and ...

Growth Hormone Releasing Peptide-6 (GHRP-6) is a synthetic hexapeptide widely examined for its potential role in stimulating ...

Novo Nordisk is doubling down on its oral drug strategy for obesity with a new partnership worth up to $2.2bn with Septerna.

Ozempic side effects are a hot topic but don’t panic – our experts are here to help. Here’s what to expect and how to ...

Individualized ocular characteristics should be considered before starting GLP-1 RA therapies for weight loss and diabetes ...

Tirzepatide (trade name Zepbound) promoted greater weight loss in individuals with obesity than did semaglutide (trade name Wegovy) in a clinical ...

Current medications for obesity and diabetes often target specific receptors in the pancreas and brain, particularly those ...

These headaches are typically a result of how the drug interacts with your body, not a direct effect of the medication.

Inflammation peptides have emerged as intriguing molecules in scientific exploration, offering various properties that may hold promise for diverse research domains.

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...